Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Cole

Showing results (51-60 of 221) with videos related to

Pageof 23
Sort By:
Journal of Clinical Pharmacology|May 1, 1976
An evaluation of papaverine in tardive dyskinesiaG Gardos, J O Cole, C Sniffin
International Pharmacopsychiatry|January 1, 1973
A controlled evaluation of pyrovalerone in chronically fatigued volunteersJ Goldberg, G Gardos, J O Cole
Current Therapeutic Research, Clinical and Experimental|January 1, 1977
Trimonam and mental retardationI Huston, C Swett, J O Cole
Archives of General Psychiatry|October 1, 1972
Therapeutic approaches to tardive dyskinesia. A review of the literatureH Kazamatsuri, C Chien, J O Cole
The American Journal of Psychiatry|December 1, 1981
Adverse effects of antiparkinson drug withdrawalT Jellinek, G Gardos, J O Cole
The American Journal of Psychiatry|November 1, 1978
Withdrawal syndromes associated with antipsychotic drugsG Gardos, J O Cole, D Tarsy
Archives of General Psychiatry|July 1, 1972
Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazateH Kazamatsuri, C Chien, J O Cole
Archives of General Psychiatry|July 1, 1972
Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazineH Kazamatsuri, C Chien, J O Cole
Annals of Neurology|July 1, 1982
Does papaverine affect brain dopamine?R J Branconnier, J O Cole, S Ghazvinian
Psychopharmacology Bulletin|January 1, 1978
ACTH4-10 in the amelioration of neuropsychological symptomatology associated with senile organic brain syndromeR J Branconnier, J O Cole, G Gardos
Pageof 23

Showing results (51-60 of 221) with videos related to

Sort By:
Pageof 23
Journal of Clinical Pharmacology|May 1, 1976
An evaluation of papaverine in tardive dyskinesiaG Gardos, J O Cole, C Sniffin
International Pharmacopsychiatry|January 1, 1973
A controlled evaluation of pyrovalerone in chronically fatigued volunteersJ Goldberg, G Gardos, J O Cole
Current Therapeutic Research, Clinical and Experimental|January 1, 1977
Trimonam and mental retardationI Huston, C Swett, J O Cole
Archives of General Psychiatry|October 1, 1972
Therapeutic approaches to tardive dyskinesia. A review of the literatureH Kazamatsuri, C Chien, J O Cole
The American Journal of Psychiatry|December 1, 1981
Adverse effects of antiparkinson drug withdrawalT Jellinek, G Gardos, J O Cole
The American Journal of Psychiatry|November 1, 1978
Withdrawal syndromes associated with antipsychotic drugsG Gardos, J O Cole, D Tarsy
Archives of General Psychiatry|July 1, 1972
Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazateH Kazamatsuri, C Chien, J O Cole
Archives of General Psychiatry|July 1, 1972
Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazineH Kazamatsuri, C Chien, J O Cole
Annals of Neurology|July 1, 1982
Does papaverine affect brain dopamine?R J Branconnier, J O Cole, S Ghazvinian
Psychopharmacology Bulletin|January 1, 1978
ACTH4-10 in the amelioration of neuropsychological symptomatology associated with senile organic brain syndromeR J Branconnier, J O Cole, G Gardos
Pageof 23